We invite you to register for our upcoming webinar: ‘Maternal Cell Contamination’ happening on Wednesday, June 23rd at 11:00 am – 12:00 pm AEST.
Maternal cell contamination (MCC) poses a preanalytical risk for errors in prenatal testing. Best practice guideline recommends the assessment of MCC in all prenatal samples, however current practices have demonstrated that the utilisation and interpretation of MCC analysis differs amongst diagnostic laboratories.
The Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP) has been running an external quality assurance program for MCC since 2006 to monitor laboratory performance in MCC analysis. This educational webinar will cover the why, how and when in MCC analysis.
We are pleased to announce the program and speakers for this event and we thank them in advance for their support.
Bruce Bennetts, Children’s Hospital at Westmead, Australia
– Why is MCC required?
– Risks of MCC for different assays
– When it may not be necessary to do a separate MCC assay
Ben Lundie, Pathology Queensland, Australia
– How is MCC measured?
– When is a loci informative?
– MCC calculations
Electra Pontikinas, SA Pathology, Australia
– What level of MCC is acceptable?
– Reporting of MCC
Richard King, Canterbury District Health Board, New Zealand